Sterling
Roche logo
Roche
AstraZeneca logo
AstraZeneca

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q4 2025: Roche 17.1305, AstraZeneca 15.384.

* Roche reports semi-annually. Values are evenly split across both quarters within each half.

Roche vs AstraZeneca Net Worth and Market Cap

Roche (RHHBY) and AstraZeneca (AZN) are peers in GLP-1. Roche reported revenue of $34.3B as of Q4 2025, compared with $15.4B for AstraZeneca. Roche leads on revenue.

Roche's gross margin is 71.7% versus 83.6% for AstraZeneca. Roche's net margin is 17.9% versus 16.3% for AstraZeneca.

Key differences

  • Revenue growth on the same quarter a year earlier: AstraZeneca +6.4% (Q2 2026), Roche -4.2% (Q4 2025).
  • Roche's KPIs on Sterling include Carmot Asset Pipeline: CT-388, CT-996, CT-868 Trial Readout Timeline and CT-868 (Acmopatide) Discontinuation.
  • AstraZeneca's KPIs on Sterling include Alliance Revenue by Partnered Medicine (Quarterly) and AZD5004 + AZD6234 Trial Timeline: Oral GLP-1 + Oral Amylin.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Roche, AstraZeneca.
MetricRocheAstraZeneca
Market Cap--
Revenue$34.26B$15.38B
Cost of Revenue$9.68B$2.52B
Gross Profit$24.58B$12.86B
Operating Income$7.96B$3.16B
Net Income$6.13B$2.51B
R&D Expense$7.48B$4.05B
Earnings Per Share$0.95$1.59
Gross Margin71.7%83.6%
Operating Margin23.2%20.6%
Net Profit Margin17.9%16.3%
Free Cash Flow$10.67B$2.13B
Cumulative Free Cash Flow$299.34B$121.22B
Operating Cash Flow$13.12B$2.89B
Cash & Equivalents$6.32B$4.89B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites